Vanguard Group’s Oruka Therapeutics ORKA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$74.4M Buy
2,453,530
+676,865
+38% +$18.9M ﹤0.01% 1983
2025
Q3
$34.2M Sell
1,776,665
-40,642
-2% -$602K ﹤0.01% 2348
2025
Q2
$20.4M Buy
1,817,307
+179,874
+11% +$1.87M ﹤0.01% 2550
2025
Q1
$16.8M Buy
1,637,433
+26,782
+2% +$334K ﹤0.01% 2586
2024
Q4
$31.2M Buy
1,610,651
+1,572,853
+4,161% +$38.4M ﹤0.01% 2369
2024
Q3
$926K Sell
37,798
-2
-0% -$70 ﹤0.01% 3799
2024
Q2
$1.74M Hold
37,800
﹤0.01% 3603
2024
Q1
$798K Hold
37,800
﹤0.01% 3884
2023
Q4
$771K Buy
37,800
+255
+0.7% +$5.73K ﹤0.01% 3906
2023
Q3
$906K Sell
37,545
-923
-2% -$22.6K ﹤0.01% 3875
2023
Q2
$937K Sell
38,468
-466
-1% -$11.5K ﹤0.01% 3923
2023
Q1
$930K Buy
38,934
+650
+2% +$17.1K ﹤0.01% 3944
2022
Q4
$1.09M Buy
38,284
+20
+0.1% +$513 ﹤0.01% 3882
2022
Q3
$946K Sell
38,264
-88
-0.2% -$2.49K ﹤0.01% 4022
2022
Q2
$1.15M Buy
38,352
+55
+0.1% +$1.55K ﹤0.01% 4041
2022
Q1
$1.06M Buy
38,297
+4,440
+13% +$110K ﹤0.01% 4188
2021
Q4
$874K Sell
33,857
-915
-3% -$27.6K ﹤0.01% 4299
2021
Q3
$1.24M Buy
34,772
+1,563
+5% +$57.8K ﹤0.01% 4201
2021
Q2
$1.39M Buy
33,209
+21,751
+190% +$907K ﹤0.01% 4075
2021
Q1
$502K Buy
11,458
+4,156
+57% +$218K ﹤0.01% 4138
2020
Q4
$351K Buy
7,302
+6,138
+527% +$306K ﹤0.01% 4018
2020
Q3
$62K Buy
+1,164
New +$82.1K ﹤0.01% 4054
2019
Q2
Sell
-234
Closed -$19K 4187
2019
Q1
$19K Hold
234
﹤0.01% 4100
2018
Q4
$17K Sell
234
-9
-4% -$1.12K ﹤0.01% 4129
2018
Q3
$29K Buy
243
+57
+31% +$7.36K ﹤0.01% 4147
2018
Q2
$22K Buy
186
+18
+11% +$2.11K ﹤0.01% 4121
2018
Q1
$18K Sell
168
-297
-64% -$79.7K ﹤0.01% 4092
2017
Q4
$138K Sell
465
-48
-9% -$13.9K ﹤0.01% 3977
2017
Q3
$122K Buy
513
+178
+53% +$63.3K ﹤0.01% 3975
2017
Q2
$177K Sell
335
-228
-40% -$119K ﹤0.01% 3922
2017
Q1
$304K Hold
563
﹤0.01% 3835
2016
Q4
$347K Hold
563
﹤0.01% 3802
2016
Q3
$351K Hold
563
﹤0.01% 3819
2016
Q2
$353K Hold
563
﹤0.01% 3850
2016
Q1
$417K Buy
563
+12
+2% +$9.76K ﹤0.01% 3827
2015
Q4
$553K Buy
551
+147
+36% +$166K ﹤0.01% 3805
2015
Q3
$434K Buy
404
+48
+13% +$73.1K ﹤0.01% 3892
2015
Q2
$619K Buy
356
+57
+19% +$74.9K ﹤0.01% 3804
2015
Q1
$362K Buy
299
+21
+8% +$24.6K ﹤0.01% 3899
2014
Q4
$401K Buy
278
+11
+4% +$16.6K ﹤0.01% 3790
2014
Q3
$505K Buy
267
+2
+0.8% +$4.18K ﹤0.01% 3706
2014
Q2
$584K Buy
265
+9
+4% +$20.9K ﹤0.01% 3637
2014
Q1
$721K Buy
256
+141
+123% +$412K ﹤0.01% 3555
2013
Q4
$292K Buy
115
+8
+7% +$18.5K ﹤0.01% 3710
2013
Q3
$257K Buy
107
+100
+1,429% +$208K ﹤0.01% 3662
2013
Q2
$13K Buy
+7
New +$21.4K ﹤0.01% 3792

Other funds holding ORKA